It is estimated that Group A rotavirus diarrhea causes as many as one
million deaths per year in children worldwide, and effective vaccines
will be essential for their control. Plasmid DNA vaccines encoding mur
ine rotaviral proteins VP4, VP6, or VP7 were tested in adult BALB/c mi
ce for their ability to induce immune responses and provide protection
against rotavirus challenge. The vaccines were administered by inocul
ation into cells of the epidermis with an Accell gene gun (Auragen, In
c., Middleton, WI, USA). Each vaccine elicited rotavirus-specific seru
m antibodies as measured by ELISA. Virus neutralizing antibodies were
detected in mice receiving plasmid DNAs encoding for outer capsid prot
eins VP4 and VP7, but not for VP6, an inner capsid protein, and all of
the vaccines generated virus-specific CTL responses. Each vaccine was
effective in protecting mice against infection after homotypic rotavi
rus (100 ID50) challenge, showing reductions (P<0.0002) in viral excre
tion measured over a 9 day period. Increased rotavirus-specific intest
inal IgA antibodies were seen in vaccinated mice after rotavirus chall
enge, particularly in mice that received the VP6 DNA vaccine. This sug
gests that intracellular IgA-mediated neutralization may be involved i
n protective immunity induced by the VP6 DNA vaccine, and may represen
t a new mechanism for protection by DNA vaccines. (C) 1997 Elsevier Sc
ience Ltd.